Antarctic Treaty Talks Break Down As Scientists Debate Impact Of Mining

Six months ago the Antarctic Minerals Convention seemed assured of passage. The treaty, eight years in the making, proposed strict—and some say neatly impossible—environmental standards for oil and mineral prospecting in the Antarctic. But today many observers believe the measure is as good as dead. Australia, France, and several other countries have withdrawn their support of the pact under pressure from environmentalists, who fear that if a mechanism—no matter how rigorou

Written byChristopher Anderson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Six months ago the Antarctic Minerals Convention seemed assured of passage. The treaty, eight years in the making, proposed strict—and some say neatly impossible—environmental standards for oil and mineral prospecting in the Antarctic. But today many observers believe the measure is as good as dead. Australia, France, and several other countries have withdrawn their support of the pact under pressure from environmentalists, who fear that if a mechanism—no matter how rigorous—is created to allow mining, then mining will inevitably take place. The dissident nations now call for a total ban on mining and the conversion of the continent into a “wilderness park,” with a perpetual moratorium on mining or drilling for oil.

In Paris last month, at the annual meeting of the 22 nations that set Antarctic policy, supporters and opponents of the mining convention clashed early and often without resolving the issue. Underneath the political debate lay an important ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies